Our software leverages advanced artificial intelligence and machine learning algorithms to design and optimize aptamers—short, single-stranded DNA or RNA molecules that bind to specific targets. The tool streamlines the discovery process, reduces experimental iterations, and delivers high-affinity, specific aptamer candidates for therapeutic, diagnostic, or research applications.